Table 3.
Go enrichment analysis of mRNAs in consecutive groups (30d vs. 90d, 90d vs. 150d, and 150d vs. 210d).
| Groups | mRNAs | lncRNAs |
|---|---|---|
| 30d vs. 90d (upregulated) | -Tissue and organ morphology development -Epithelial and endothelial cell proliferation -Extracellular matrix -Cell adhesion -Calcium ion binding |
-Zinc ion binding -Transition metal element ion binding -Transcription factor complex -Steroid hormone receptor activity |
| 90d vs. 150d (upregulated) | -Protein folding -Chaperone-mediated protein folding |
-RNA binding -Positive regulation of epithelial cell -proliferation -Male gonadal development -Cell response to peptides |
| 150d vs. 210d (upregulated) | -Sterol homeostasis and transport, -Lipoprotein particles, -High-density lipoprotein particles, -Cholesterol homeostasis and transport activity |
-Transferase activity -DNA polymerase activity -Nucleotide transaminase activity -Nuclease activity -Endonuclease activity -Hydrolase activity acting on ester bonds |
| 30d vs. 90d (downregulated) | -Steroid dehydrogenase activity -Steroid metabolism -RNA-guided DNA polymerase activity -Organic acid biosynthesis -Cellular amino acid metabolism -Catalytic activity on DNA |
-Catalytic activity -Hydrolase activity -Myosin filaments -Myosin complex |
| 90d vs. 150d (downregulated) | -Transferase activity -DNA polymerase activity -Nuclease activity -Nucleotide transferase activity -Hydrolase activity acting on ester bonds -Steroid dehydrogenase activity |
-Protein-DNA complexes -Protein heterodimers and dimer activity -Nucleosomes -DNA packaging complexes and chromatin parts |
| 150d vs. 210d (downregulated) | -Protein folding -Chaperone-mediated protein folding -Protein stability regulation |
-Thyroid development -Signal pathway mediated by thyroid hormone -Negative regulation of transcription initiation by RNA polymerase II promoter |